Home > News > news details
+ NEWS DETAILS
2019-10-31CE Approval for Rhea Autologous Bioactive Molecules Enrich System

We are glad to announce our Rhea Autologous Bioactive Molecules Enrich System has passed CE approval in July 2019!

"Rhea" is the brand new device for preparing PRP applied in ocular surface diseases, such as Dry Eye Syndrome and Corneal Ulcer.

In just 5 minutes, an 18-30ml of solution is prepared automatically, with a great formulation for ophthalmic use, as well as wound care application.

Copyright ® 2010 Safetran Corporation All rights reserved. Designed by:iware網頁設計